Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v4-FR
Language French French
Date Updated 2017-09-13 2017-06-21
Drug Identification Number 02240115 02240115
Brand name LAMICTAL LAMICTAL
Common or Proper name Lamotrigine chewable/dispersible tablets Lamotrigine chewable/dispersible tablets
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients LAMOTRIGINE LAMOTRIGINE
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 28's 28's
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2017-07-27
Actual start date 2017-07-17
Estimated end date 2017-09-07 Unknown
Actual end date 2017-09-08
Shortage status Resolved Anticipated shortage
Company comments For emergency supply, contact GSK Customer Service 1-800-387-7374.
Health Canada comments